Dosimetric analysis of patients with gastro entero pancreatic neuroendocrine tumors (NETs) treated with PRCRT (peptide receptor chemo radionuclide therapy) using Lu-177 DOTATATE and capecitabine/temozolomide (CAP/TEM)-Reference-Cited by-同舟云学术

Dosimetric analysis of patients with gastro entero pancreatic neuroendocrine tumors (NETs) treated with PRCRT (peptide receptor chemo radionuclide therapy) using Lu-177 DOTATATE and capecitabine/temozolomide (CAP/TEM)

Published:2018-11 Issue:1091 Volume:91 Page:20170172
ISSN:0007-1285
Container-title:The British Journal of Radiology
language:en
Short-container-title:BJR

Author:

Thakral Parul¹,Sen Ishita¹,Pant Vineet¹,Gupta Santosh Kumar²,Dureja Sugandha¹,Kumari Jyotsna¹,Kumar Sunil¹,UN Pallavi¹,Malasani Vindhya¹

Affiliation:

1. Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India

2. Department of Physics, Guru Ghasidas University Bilaspur, Chattisgarh, India

Publisher

British Institute of Radiology

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://www.birpublications.org/doi/pdf/10.1259/bjr.20170172

Reference32 articles.

1. Lutetium-labelled peptides for therapy of neuroendocrine tumours

2. Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

3. Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE

4. Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment

5. [177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of Coincidence Detection of Cascade Photons to Enhance Preclinical Multi-Radionuclide SPECT Imaging;IEEE Transactions on Medical Imaging;2024-05

2. Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors;Current Oncology Reports;2024-04-10

3. Impact of different models based on blood samples and images for bone marrow dosimetry after 177Lu-labeled somatostatin-receptor therapy;EJNMMI Physics;2024-04-02

4. The Role of Chemotherapy in Neuroendocrine Tumors;Neuroendocrine Tumours;2024

5. Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics;Journal of Nuclear Medicine;2023-09-21